{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014972","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.201062+00:00","generated_at":"2026-05-19T09:12:02.405290+00:00","sec_items":["1.01","2.03","3.02","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Indaptus raises $2.3M via convertible notes and warrants; up to $5M total","bullets":["$2.3M aggregate principal of 6% convertible promissory notes; mature July 28, 2026.","Conversion at 80% of 5-day VWAP, max $0.40; warrants for 200% of conversion shares after approval.","Net proceeds for R&D, Phase 1b/2 trial funding, and general working capital.","Offering may increase to $5M; Paulson Investment Company is exclusive placement agent with 12% fee.","Company must hold special meeting for stockholder approval; note conversion tied to reverse split or 1 year."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014972","json":"https://secwatch.observer/filing/0001641172-25-014972.json","markdown":"https://secwatch.observer/filing/0001641172-25-014972.md","text":"https://secwatch.observer/filing/0001641172-25-014972.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/0001641172-25-014972-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T09:12:02.405290+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9f8d6b994f442e4d6b5d1d4dd6e00c40cd9881e","claim":"Indaptus Therapeutics, Inc. incurred convertible notes of aggregate principal amount of $2.3 million with certain accredited investors at 6% per year maturing July 28, 2026.","evidence_excerpt":"the offering in a private placement of convertible promissory notes in the aggregate principal amount of $2.3 million (the \"Notes\") and warrants (the \"Warrants\") to purchase shares of common stock, par value $0.01 per share (\"Common Stock\"). The closing of private placement occurred on June 12, 2025","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225014972/0001641172-25-014972-index.htm","confidence":0.98,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"aggregate principal amount of $2.3 million"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Rate","value":"6% per year"},{"label":"Maturity","value":"July 28, 2026"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}